|
Research Symposium Inflammation, Diabetes and Cardiovascular Disease: Emerging Science and Clinical Implications September 30 - October 2, 2004
PROGRAM SCHEDULE Thursday, September 30, 20044:00 p.m. 8:00 p.m. Registration and Poster Set-up 6:00 p.m. 7:00 p.m. Reception
Friday, October 1, 20047:30 a.m. 8:20 a.m. Breakfast 7:30 a.m. 3:00 p.m. Registration and Information 8:20 a.m. 8:30 a.m. Introduction Vivian Fonseca, MD, New Orleans, Louisiana, U.S.A.
Session 1 8:30 a.m. 9:00 a.m. What is the Immunology of Inflammation? Stephen Desiderio, MD, PhD, Baltimore, Maryland, U.S.A.
9:00 a.m. 9:30 a.m. Natural History of Inflammation Wolfgang Koenig, MD, Ulm, Germany
9:30 a.m. 10:00 a.m. Cellular and Molecular Regulation of Inflammation Jorge Plutzky, MD, Boston, Massachusetts, U.S.A.
10:00 a.m. 10:30 a.m. Morning Break
10:30 a.m. 11:00 a.m. Cytokines and Inflammation Paresh Dandona, MD, PhD, Buffalo, New York, U.S.A.
11:00 a.m. 11:30 a.m. Triggers of Inflammation: Environmental and Genetics James Pankow, PhD, Minneapolis, Minnesota, U.S.A.
11:30 a.m. 12:00 p.m. Inflammation and Vascular Function Ishwarlal Jialal, MD, PhD, Sacramento, California, U.S.A.
12:00 p.m. 12:30 p.m. Session 1 Panel Discussion Moderator: Vivian Fonseca, MD
12:30 p.m. 2:00 p.m. Lunch and Poster Viewing
Session 2 2:00 p.m. 2:30 p.m. The Relationship between Insulin Resistance, Diabetes and Cardiovascular Disease Steven Haffner, MD, San Antonio, Texas, U.S.A.
2:30 p.m. 3:00 p.m. The Relationship between Inflammation and Cardiovascular Disease Paul Ridker, MD, Boston, Massachusetts, U.S.A. (Invited)
3:00 p.m. 3:30 p.m. Pathophysiological Mechanisms Linking Inflammation to Insulin Resistance Morris F. White, PhD, Boston, Massachusetts, U.S.A.
3:30 p.m. 3:45 p.m. Break
3:45 p.m. 4:15 p.m. Epidemiology of Cardiovascular Disease in Autoimmune Disease Cornelia M. Weyand, MD, PhD, Atlanta, Georgia, U.S.A.
4:15 p.m. 4:45 p.m. Session 2 Panel Discussion Moderator: Steven Haffner, MD
4:45 p.m. 5:30 p.m. Oral Presentations
6:00 p.m. 7:00 p.m. Reception in Poster Hall
7:00 p.m. 8:00 p.m. Dinner
Saturday, October 2, 20047:30 a.m. 8:30 a.m. Breakfast 7:30 a.m. 3:00 p.m. Registration and Information
Session 3 8:30 a.m. 9:00 a.m. Is Inflammation a Risk Factor or Marker? Frederick Brancati, MD, Baltimore, Maryland, U.S.A.
9:00 a.m. 9:30 a.m. Laboratory Assessment of Inflammation Russell P. Tracey, MD, Burlington, Vermont, U.S.A.
9:30 a.m. 10:00 a.m. Clinical Indicators for Testing Michael H. Criqui, MD, MPH, La Jolla, California, U.S.A.
10:00 a.m. 10:30 a.m. Morning Break
10:30 a.m. 11:00 a.m. Lifestyle Modification to Affect Inflammation Xavier Pi-Sunyer, MD, MPH, New York, New York, U.S.A.
11:00 a.m. 11:30 a.m. Pharmacologic Approaches to Reducing Inflammation Vivian Fonseca, MD, New Orleans, Louisiana, U.S.A.
11:30 a.m. 12:00 p.m. Should the Presence of Inflammation Modify the Goals of Therapy to Prevent Cardiovascular Disease? Scott M. Grundy, MD, PhD, Dallas, Texas, U.S.A. (Invited)
12:00 p.m. 12:30 p.m. Session 3 Panel Discussion Frederick Brancati, MD |
|
|
|
|